QuantuMDx Group Ltd (QuantuMDx) operates as a developer of science tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases and companion diagnostics assays and tumour profiling. QuantuMDx also develops technologies such as Q-PREP, Q-AMP, Q-DETECT, and Q-SEQ. The company’s devices are built using a range of complex technologies such as nanowires, microfluidic technologies, and molecular biology techniques. It serves clinics, pharmacies, hospitals and labs. The company has operations in the US and Singapore. QuantuMDx is headquartered in Newcastle Upon Tyne, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company QuantuMDx Group Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- QuantuMDx Group Ltd Company Overview
- QuantuMDx Group Ltd Company Snapshot
- QuantuMDx Group Ltd Pipeline Products and Ongoing Clinical Trials Overview
- QuantuMDx Group Ltd - Pipeline Analysis Overview
- QuantuMDx Group Ltd - Key Facts
- QuantuMDx Group Ltd - Major Products and Services
- QuantuMDx Group Ltd Pipeline Products by Development Stage
- QuantuMDx Group Ltd Pipeline Products Overview
- Adult (in-patient) Respiratory Diagnostic Assay Panel
- Adult (in-patient) Respiratory Diagnostic Assay Panel Product Overview
- Diagnostic Assay - Tuberculosis (Latent and Drug Resistant)
- Diagnostic Assay - Tuberculosis (Latent and Drug Resistant) Product Overview
- Diagnostic Assay Panel - Gastrointestinal Diseases
- Diagnostic Assay Panel - Gastrointestinal Diseases Product Overview
- Diagnostic Assay Panel - Healthcare Associated Infections
- Diagnostic Assay Panel - Healthcare Associated Infections Product Overview
- Diagnostic Assay Panel - Hepatitis
- Diagnostic Assay Panel - Hepatitis Product Overview
- Diagnostic Assay Panel - Meningitis/Encephalitis
- Diagnostic Assay Panel - Meningitis/Encephalitis Product Overview
- Diagnostic Assay Panel - Urinary Tract Infections
- Diagnostic Assay Panel - Urinary Tract Infections Product Overview
- Diagnostic Device - Sepsis
- Diagnostic Device - Sepsis Product Overview
- DNA-XT
- DNA-XT Product Overview
- Paediatric (in-patient) Respiratory Diagnostic Assay Panel
- Paediatric (in-patient) Respiratory Diagnostic Assay Panel Product Overview
- Q-CANCER
- Q-CANCER Product Overview
- Q-POC - BRAF/MSI
- Q-POC - BRAF/MSI Product Overview
- Q-POC - Cancer Test
- Q-POC - Cancer Test Product Overview
- Q-POC - CML Assay
- Q-POC - CML Assay Product Overview
- Q-POC - Dengue Fever Assay
- Q-POC - Dengue Fever Assay Product Overview
- Q-POC - EGFR NSCLC Assay
- Q-POC - EGFR NSCLC Assay Product Overview
- Q-POC - HIV Assay
- Q-POC - HIV Assay Product Overview
- Q-POC - HPV Assay
- Q-POC - HPV Assay Product Overview
- Q-POC - Influenza Assay
- Q-POC - Influenza Assay Product Overview
- Q-POC - Malaria Detection Device
- Q-POC - Malaria Detection Device Product Overview
- Q-POC - MDR-TB
- Q-POC - MDR-TB Product Overview
- Q-POC - MRSA/C.Diff
- Q-POC - MRSA/C.Diff Product Overview
- Q-POC - Mycoplasma Assay Cassette
- Q-POC - Mycoplasma Assay Cassette Product Overview
- Q-POC - Sexually Transmitted Diseases
- Q-POC - Sexually Transmitted Diseases Product Overview
- Q-POC - Tropical Disease Test
- Q-POC - Tropical Disease Test Product Overview
- Q-POC 2.0
- Q-POC 2.0 Product Overview
- Q-POC Disposable Cartridge - Cardiovascular Diseases
- Q-POC Disposable Cartridge - Cardiovascular Diseases Product Overview
- Q-POC+
- Q-POC+ Product Overview
- QuantuMDx SARS-CoV-2 RT-PCR Detection Assay
- QuantuMDx SARS-CoV-2 RT-PCR Detection Assay Product Overview
- SARS-CoV-2 Saliva Test
- SARS-CoV-2 Saliva Test Product Overview
- QuantuMDx Group Ltd - Key Competitors
- QuantuMDx Group Ltd - Key Employees
- QuantuMDx Group Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- QuantuMDx Group Ltd, Recent Developments
- Sep 06, 2022: QuantuMDx and Sansure partner to commercialise Q-POC platform in China
- May 26, 2021: QuantuMDx appoints Mirre de Noo as Non-Executive Director
- Feb 13, 2021: Prime Minister, Boris Johnson visits QuantuMDx
- Jan 21, 2021: QuantuMDx appoints Chief Commercial Officer
- Jan 27, 2020: QuantuMDx: Leadership changes and business update
- Nov 07, 2019: Find Initiates Feasibility Studies For Rapid, Low-Cost Diagnostics To Distinguish Gonorrhoea From Chlamydia In Primary Care Clinics
- Apr 17, 2019: QuantuMDx Group has announced plans to expand the potential of its Q-POC technology and develop a quality control analytics system for cell and gene therapies (“C”s), to be evaluated by GlaxoSmithKline’s C platform group.
- Apr 17, 2019: QuantuMDx develops QC analytics system for cell & gene therapies
- Jan 23, 2019: QuantuMDx & St George’s begin field study: cervical cancer screening test
- Sep 12, 2018: QuantuMDx announces senior management changes
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- QuantuMDx Group Ltd Pipeline Products and Ongoing Clinical Trials Overview
- QuantuMDx Group Ltd Pipeline Products by Equipment Type
- QuantuMDx Group Ltd Pipeline Products by Indication
- QuantuMDx Group Ltd, Key Facts
- QuantuMDx Group Ltd, Major Products and Services
- QuantuMDx Group Ltd Number of Pipeline Products by Development Stage
- QuantuMDx Group Ltd Pipeline Products Summary by Development Stage
- Adult (in-patient) Respiratory Diagnostic Assay Panel - Product Status
- Adult (in-patient) Respiratory Diagnostic Assay Panel - Product Description
- Diagnostic Assay - Tuberculosis (Latent and Drug Resistant) - Product Status
- Diagnostic Assay - Tuberculosis (Latent and Drug Resistant) - Product Description
- Diagnostic Assay Panel - Gastrointestinal Diseases - Product Status
- Diagnostic Assay Panel - Gastrointestinal Diseases - Product Description
- Diagnostic Assay Panel - Healthcare Associated Infections - Product Status
- Diagnostic Assay Panel - Healthcare Associated Infections - Product Description
- Diagnostic Assay Panel - Hepatitis - Product Status
- Diagnostic Assay Panel - Hepatitis - Product Description
- Diagnostic Assay Panel - Meningitis/Encephalitis - Product Status
- Diagnostic Assay Panel - Meningitis/Encephalitis - Product Description
- Diagnostic Assay Panel - Urinary Tract Infections - Product Status
- Diagnostic Assay Panel - Urinary Tract Infections - Product Description
- Diagnostic Device - Sepsis - Product Status
- Diagnostic Device - Sepsis - Product Description
- DNA-XT - Product Status
- DNA-XT - Product Description
- Paediatric (in-patient) Respiratory Diagnostic Assay Panel - Product Status
- Paediatric (in-patient) Respiratory Diagnostic Assay Panel - Product Description
- Q-CANCER - Product Status
- Q-CANCER - Product Description
- Q-POC - BRAF/MSI - Product Status
- Q-POC - BRAF/MSI - Product Description
- Q-POC - Cancer Test - Product Status
- Q-POC - Cancer Test - Product Description
- Q-POC - CML Assay - Product Status
- Q-POC - CML Assay - Product Description
- Q-POC - Dengue Fever Assay - Product Status
- Q-POC - Dengue Fever Assay - Product Description
- Q-POC - EGFR NSCLC Assay - Product Status
- Q-POC - EGFR NSCLC Assay - Product Description
- Q-POC - HIV Assay - Product Status
- Q-POC - HIV Assay - Product Description
- Q-POC - HPV Assay - Product Status
- Q-POC - HPV Assay - Product Description
- Q-POC - Influenza Assay - Product Status
- Q-POC - Influenza Assay - Product Description
- Q-POC - Malaria Detection Device - Product Status
- Q-POC - Malaria Detection Device - Product Description
- Q-POC - MDR-TB - Product Status
- Q-POC - MDR-TB - Product Description
- Q-POC - MRSA/C.Diff - Product Status
- Q-POC - MRSA/C.Diff - Product Description
- Q-POC - Mycoplasma Assay Cassette - Product Status
- Q-POC - Mycoplasma Assay Cassette - Product Description
- Q-POC - Sexually Transmitted Diseases - Product Status
- Q-POC - Sexually Transmitted Diseases - Product Description
- Q-POC - Tropical Disease Test - Product Status
- Q-POC - Tropical Disease Test - Product Description
- Q-POC 2.0 - Product Status
- Q-POC 2.0 - Product Description
- Q-POC Disposable Cartridge - Cardiovascular Diseases - Product Status
- Q-POC Disposable Cartridge - Cardiovascular Diseases - Product Description
- Q-POC+ - Product Status
- Q-POC+ - Product Description
- QuantuMDx SARS-CoV-2 RT-PCR Detection Assay - Product Status
- QuantuMDx SARS-CoV-2 RT-PCR Detection Assay - Product Description
- SARS-CoV-2 Saliva Test - Product Status
- SARS-CoV-2 Saliva Test - Product Description
- QuantuMDx Group Ltd, Key Employees
- QuantuMDx Group Ltd, Other Locations
- QuantuMDx Group Ltd, Subsidiaries
- Glossary
- QuantuMDx Group Ltd Pipeline Products by Equipment Type
- QuantuMDx Group Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- PrimerDesign Ltd
- Kalon Biological Ltd
- Fortress Diagnostics Ltd
- Fortress Diagnostics Ltd
- PrimerDesign Ltd
- Kalon Biological Ltd